ALB and chronic kidney disease: A meta-analysis determining associations of kidney disease parameters with mortality and end-stage renal disease (ESRD) in individuals with diabetes has shown that the addition of eGFR and urinary albumin-to-creatinine ratio (UACR) significantly improved the prediction of cardiovascular outcomes and mortality beyond conventional risk factors [5]. A new CKD classification, which includes both GFR and albuminuria stages, has been adopted to provide a more accurate assessment of renal and cardiovascular outcomes [6].